Treatment quality and outcome for multidrug-resistant tuberculosis patients in four regions of China: a cohort study

BACKGROUND: China incurs an extremely low treatment coverage of multidrug-resistant tuberculosis (MDR-TB). This study aimed to understand the experience of MDR-TB patients on quality of health care, and the clinical impact through an up to six-year follow-up. METHODS: Cohorts of MDR-TB patients were...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Xu-Bin, Diwan, Vinod K., Zhao, Qi, Hu, Yi, Bruchfeld, Judith, Jiang, Wei-Li, Hoffner, Sven, Xu, Biao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368741/
https://www.ncbi.nlm.nih.gov/pubmed/32682446
http://dx.doi.org/10.1186/s40249-020-00719-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368741/
https://www.ncbi.nlm.nih.gov/pubmed/32682446
http://dx.doi.org/10.1186/s40249-020-00719-x

Ejemplares similares